VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.5500
+0.0200 (3.77%)
At close: Mar 28, 2025, 4:00 PM
0.5599
+0.0099 (1.80%)
After-hours: Mar 28, 2025, 7:58 PM EST
VolitionRx Employees
VolitionRx had 110 employees as of December 31, 2023. The number of employees increased by 6 or 5.77% compared to the previous year.
Employees
110
Change (1Y)
6
Growth (1Y)
5.77%
Revenue / Employee
$11,689
Profits / Employee
-$271,570
Market Cap
50.97M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VNRX News
- 2 days ago - Volition Announces Two Poster Presentations at ESMO's European Lung Cancer Congress 2025 - PRNewsWire
- 3 days ago - Volition to Host Virtual Investor Event on Nu.Q® Cancer, "A Look to the Future of Cancer Diagnostics", on April 9, 2025 - PRNewsWire
- 4 days ago - VolitionRx Announces Pricing of up to $2.3 Million Registered Direct Offering - PRNewsWire
- 5 days ago - VolitionRx Limited Schedules Full Fiscal Year 2024 Earnings Conference Call and Business Update - PRNewsWire
- 9 days ago - Volition's Nu.Q® Cancer Diagnostics Test Aims To Disrupt the Multi-Billion Dollar Liquid Biopsy Industry - PRNewsWire
- 10 days ago - Volition Introduces Nu.Q® Cancer Blood Test in New Industry Primer for Lung Cancer - PRNewsWire
- 13 days ago - Volition Proudly Sponsors the 44th ISICEM Congress - PRNewsWire
- 17 days ago - Volition Signs first ever Nu.Q® Vet Cancer Test Automation Agreement with Fujifilm Vet Systems - PRNewsWire